Documente Academic
Documente Profesional
Documente Cultură
Autoimmune
hemolytic anemia
Rheumatic heart
disease
Thrombocytopenia Antibody (IgM or IgG) binds to antigen on
Erythroblastosis a target cell, which is actually a host cell
Cytotoxic, antibody- fetalis IgM or IgG that is perceived by the immune system
II Complement as foreign, leading to cellular destruction
dependent Goodpasture's
syndrome MAC via the MAC. Testing includes both the
Graves' disease direct and indirect Coombs test.[3]
*see type V
explanation below
Myasthenia gravis
*see type V
explanation below
Serum sickness
Rheumatoid
arthritis
Arthus reaction
Post streptococcal
glomerulonephritis Antibody (IgG) binds to soluble antigen,
Membranous IgG forming a circulating immune complex.
Immune complex nephropathy This is often deposited in the vessel walls
III Complement
disease of the joints and kidney, initiating a local
Reactive arthritis
Neutrophils
Lupus nephritis inflammatory reaction.[4]
Systemic lupus
erythematosus
Extrinsic allergic
alveolitis
(hypersensitivity
pneumonitis)
https://en.wikipedia.org/wiki/Hypersensitivity 2/4
4/26/2019 Hypersensitivity - Wikipedia
Hashimoto's
thyroiditis - Some
type 2. Mostly
type 4.
Granuloma
annulare
Autoimmune
disease, receptor Graves' disease IgM or IgG
V
mediated (see
Myasthenia gravis Complement
below)
Type V
This is an additional type that is sometimes (especially in the UK) used as a distinction from Type 2.[7]
Instead of binding to cell surfaces, the antibodies recognise and bind to the cell surface receptors, which either prevents
the intended ligand binding with the receptor or mimics the effects of the ligand, thus impairing cell signaling.
Graves' disease
Myasthenia gravis
The use of Type 5 is rare. These conditions are more frequently classified as Type 2, though sometimes they are specifically
segregated into their own subcategory of Type 2.
See also
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Type V hypersensitivity
Intolerance
References
1. Gell PGH, Coombs RRA, eds. Clinical Aspects of Immunology. 1st ed. Oxford, England: Blackwell; 1963. Section IV,
Chapter 1
2. Black, C. A. (1999). "Delayed type hypersensitivity: Current theories with an historic perspective" (http://escholarship.
org/uc/item/2fw0g1xx). Dermatology Online Journal. 5 (1): 7. PMID 10673450 (https://www.ncbi.nlm.nih.gov/pubmed/
10673450).
3. Delayed Hypersensitivity Reactions (https://emedicine.medscape.com/article/136118-overview) at eMedicine
4. Kumar, Vinay; Abbas, Abul K.; Aster, Jon C., eds. (2014). "Hypersensitivity: Immunologicaly Mediated Tissue Injury"
(https://books.google.com/books?id=5NbsAwAAQBAJ&pg=PA200). Robbins & Cotran Pathologic Basis of Disease
(9th ed.). Elsevier Health Sciences. pp. 200–11. ISBN 978-0-323-29635-9.
5. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). "Table 5-1". Robbins Basic
Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
6. Le, Tau. First Aid for the USMLE Step 1 2013, p. 203-204
https://en.wikipedia.org/wiki/Hypersensitivity 3/4